Walgreen — Merger or Acquisition (August 2014)
40 slides from Walgreen's merger presentation, Aug 6, 2014
Slide 1: Walgreens-Alliance Boots Investor Call
Exhibit 99.1 Walgreens-Alliance Boots Investor Call August 6, 2014
Slide 2: Investor Call Agenda
Investor Call Agenda Introduction & Safe Harbor Rick Hans, CFA Divisional Vice President, Investor Relations & Finance, Walgreens Alliance Boots Step 2 Update Greg Wasson President & Chief Executive Officer, Walgreens Global Management Structure Introducing: Tim McLevish EVP & Chief Financial Office
Slide 3: Safe Harbor and Non-GAAP
Safe Harbor and Non-GAAP Certain statements and projections of future results made in these presentations constitute forward-looking statements that are based on current market, competitive and regulatory expectations that involve risk and uncertainty that could cause results to vary materially. Exc
Slide 4: Walgreens-Alliance Boots Investor Call
Walgreens-Alliance Boots Investor Call Greg Wasson President & CEO, Walgreens August 6, 2014
Slide 5: Walgreens to Combine with Alliance Boots
Walgreens to Combine with Alliance Boots Walgreens exercises option to acquire remaining 55% of Alliance Boots New holding company name to be Walgreens Boots Alliance, Inc. Transaction expected to close in 1 st quarter of calendar year 2015 † † Forward-Looking Statements – See Cautionary Note in att
Slide 6: Compelling Strategic and Financial Rationale
Compelling Strategic and Financial Rationale COMPLEMENTARY CAPABILITIES & ASSETS SUBSTANTIAL SYNERGY POTENTIAL Procurement Revenue Enhancing Prescription drugs Beauty Branded goods Own brands Private brands Wellness solutions Indirect spend Best & Next Practices Store formats Loyalty E-commerce Phar
Slide 7: Leader on a Global Scale
Leader on a Global Scale Our Combined Assets Employees 350,000 Stores ~11,000* Distribution Centers 370 Global Pharmacy Distribution Points ~180,000 Global Healthcare Service Providers ~92,000 Active Loyalty Members ~100,000,000 7 *Excludes the pending 1,400 store FASA acquisition by Alliance Boots
Slide 8: Step 2 - Transaction Terms
Step 2 - Transaction Terms Step 1 Step 2 † Total † Cash $4.0 B $5.3 B* $9.3 B* Walgreens Shares Issued 83.4 M 144.3 M 227.7M TERMS STEP TWO (Option Exercise) † Structure • Purchase of remaining 55% equity interest in Alliance Boots Consideration • 3.1 B Pounds Sterling ($5.3 B*) • Shares fixed at 14
Slide 9: Blended Management Team
Blended Management Team Title Name President & CEO, Walgreens Boots Alliance, Inc. Greg Wasson Executive Vice Chairman, Strategy & New Market Development Stefano Pessina EVP, Walgreens Boots Alliance, Ornella Barra President & Chief Executive, Global Wholesale & International Retail EVP, Walgreens B
Slide 10: Domicile of Combined Enterprise
Domicile of Combined Enterprise U.S. Domicile Walgreens Boots Alliance, Inc. Global Headquarters in Chicago area Walgreens Operational Headquarters Deerfield, IL Boots Operational Headquarters Nottingham, U.K. Rationale of U.S. Domicile The Company and Board undertook a balanced, rigorous, and exten
Slide 11: Next Chapter Plan
Next Chapter Plan 3 Focus Areas to Accelerate Core Business Performance Differentiated Integrated Pharmacy Global Pharmaceutical Retail Experience and Health Care Services 11
Slide 12: Establishing New Fiscal 2016 Goals
Establishing New Fiscal 2016 Goals FY 2016 Goals† Revenue* $126 - $130 Billion Adjusted EPS** $4.25 - $4.60 †Forward-Looking Statements – See cautionary note in attached Appendix. All figures assume constant currency and current management assumptions regarding future interest rates. Also assumes cl
Slide 13: Cost Savings Plan
Cost Savings Plan Accelerating a broad $1B cost savings plan for Walgreens by FY 2017 Key Areas of Cost Focus Store Field Distribution Corporate Additional cost savings opportunities beyond 2016 will come from combined entity post integration 13
Slide 14: Capital Structure
Capital Structure Balanced and disciplined approach to capital allocation Returning cash to shareholders through dividends and share repurchases Capital Allocation Priorities Invest in Core Investing across core businesses at suitable returns to drive organic growth Business Pursue Strategic Pursuin
Slide 15: Near Term Outlook – 4Q14
Near Term Outlook – 4Q14 Metrics Expectations † Operating Income (GAAP) Expected to be down Year over Adjusted Gross Profit Margin* Year similar to 3Q14 Synergies Last Year’s 4Q included net gains from certain litigation matters that Adjusted SG&A $ Growth* reduced adjusted SG&A $ growth by 90bps Ne
Slide 16: Longer Term Opportunities
Longer Term Opportunities † Additional Synergies Aging Population Owned Brand Expansion Bigger in Beauty Growth in Pharmacy, Health and Wellness International Expansion 16 † Forward-Looking Statements – See Cautionary Note in attached Appendix
Slide 17: Global Outlook
Global Outlook Stefano Pessina Executive Chairman, Alliance Boots August 6, 2014
Slide 18: Global Outlook
Global Outlook Two Iconic Retail Pharmacy Brands Focused on Creating Shareholder Value 18
Slide 19: Appendix
Appendix The following information provides reconciliations of the supplemental non-GAAP financial measures, as defined under SEC rules, presented in this presentation to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting princip
Slide 20: Reconciliation of Adjusted Gross Profit & Margin
Reconciliation of Adjusted Gross Profit & Margin $ in Millions 4Q08 1Q09 2Q09 3Q09 4Q09 Net sales (GAAP) $ 14,597 $ 14,947 $ 16,475 $ 16,210 $ 15,703 Gross profit (GAAP) $ 4,035 $ 4,151 $ 4,657 $ 4,459 $ 4,346 LIFO provision 24 43 49 32 48 Adjusted gross profit (Non-GAAP) $ 4,059 $ 4,194 $ 4,706 $ 4
Slide 21: Reconciliation of Adjusted Gross Profit & Margin
Reconciliation of Adjusted Gross Profit & Margin $ in Millions 1Q10 2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 Net sales (GAAP) $ 16,364 $ 16,987 $ 17,199 $ 16,870 $ 17,344 $ 18,502 $ 18,371 $ 17,967 Gross profit (GAAP) $ 4,538 $ 4,897 $ 4,749 $ 4,792 $ 4,945 $ 5,324 $ 5,154 $ 5,069 LIFO provision 34 27 18
Slide 22: Reconciliation of Adjusted Gross Profit & Margin
Reconciliation of Adjusted Gross Profit & Margin $ in Millions 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 Net sales (GAAP) $ 18,157 $ 18,651 $ 17,752 $ 17,073 $ 17,316 $ 18,647 $ 18,313 $ 17,941 Gross profit (GAAP) $ 5,104 $ 5,389 $ 5,014 $ 4,835 $ 5,099 $ 5,607 $ 5,222 $ 5,191 LIFO provision 45 72 60
Slide 23: Reconciliation of Adjusted Gross Profit & Margin
Reconciliation of Adjusted Gross Profit & Margin $ in Millions 1Q14 2Q14 3Q14 Net sales (GAAP) $ 18,329 $ 19,605 $ 19,401 Gross profit (GAAP) $ 5,152 $ 5,650 $ 5,440 LIFO provision 58 51 41 Organizational Efficiency Costs 5 - - Adjusted gross profit (Non-GAAP) $ 5,215 $ 5,701 $ 5,481 YOY Change Gros
Slide 24: Reconciliation of Adjusted SG&A
Reconciliation of Adjusted SG&A $ in Millions 4Q08 1Q09 2Q09 3Q09 4Q09 Selling general and administrative expenses (GAAP) $ 3,324 $ 3,482 $ 3,627 $ 3,613 $ 3,644 Acquisition-related amortization 26 35 35 38 40 Alliance Boots transaction costs - - - - - Adjusted selling general and administrative exp
Slide 25: Reconciliation of Adjusted SG&A
Reconciliation of Adjusted SG&A $ in Millions 1Q10 2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 Selling general and administrative expenses (GAAP) $ 3,741 $ 3,811 $ 3,920 $ 4,046 $ 4,004 $ 4,117 $ 4,203 $ 4,237 Acquisition-related amortization 39 38 52 53 52 46 54 67 Alliance Boots transaction costs - - - - -
Slide 26: Reconciliation of Adjusted SG&A
Reconciliation of Adjusted SG&A $ in Millions 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 Selling general and administrative expenses (GAAP) $ 4,204 $ 4,284 $ 4,141 $ 4,249 $ 4,398 $ 4,497 $ 4,362 $ 4,286 Acquisition-related amortization 60 61 64 70 74 75 67 73 Acquisition-related costs - - 19 50 37 21
Slide 27: Reconciliation of Adjusted SG&A
Reconciliation of Adjusted SG&A $ in Millions 1Q14 2Q14 3Q14 Selling general and administrative expenses (GAAP) $ 4,379 $ 4,569 $ 4,551 Acquisition-related amortization 70 73 71 Acquisition-related costs 25 17 20 Hurricane Sandy - - - DEA Settlement Costs - - - Store Closures and other optimization
Slide 28: Reconciliation of Adjusted Operating Income
Reconciliation of Adjusted Operating Income $ in Millions Alliance Adjusted Operating Acquisition Hurricane Acquisition LIFO DEA Boots Fair Gain on WHI Organizational Operating Income Related Related Settlement Value of Sandy Provision Sale Efficiency Costs Income (Non- (GAAP) Costs Amortization Cos
Slide 29: Reconciliation of Adjusted Operating Income
Reconciliation of Adjusted Operating Income $ in Millions Alliance Store Closure and Operating Acquisition Hurricane Acquisition LIFO DEA Boots Fair Gain on WHI Other Adjusted Income Related Related Settlement Value of Operating Income Sandy Provision Sale Optimization (GAAP) Costs Amortization Cost
Slide 30: Reconciliation of Adjusted Net Earnings
Reconciliation of Adjusted Net Earnings $ in Millions Fair Market Net Acquisition Acquisition Gain on DEA Organizational Alliance Adjusted Net Hurricane LIFO Value of Medicare Earnings Related Sandy Related Provision WHI warrants Settlement Part D Efficiency Boots Related Earnings (GAAP) Costs Amort
Slide 31: Reconciliation of Adjusted Net Earnings
Reconciliation of Adjusted Net Earnings $ in Millions Store Net Acquisition Acquisition Gain on Fair Market DEA Closures and Alliance Adjusted Net Hurricane LIFO Medicare Earnings Related Related Provision WHI Value of Settlement Part D other Boots Related Earnings (GAAP) Costs Sandy Amortization Sa
Slide 32: Reconciliation of Adjusted Diluted EPS
Reconciliation of Adjusted Diluted EPS Alliance Organiza- Alliance Adjusted Diluted Acquisition Acquisition Fair Market Gain DEA Boots Share Hurricane LIFO Value of Medicare tional Boots Diluted EPS Related Related warrants on WHI Settlement Efficiency (GAAP) Costs Issuance Sandy Amortization Provis
Slide 33: Reconciliation of Adjusted Diluted EPS
Reconciliation of Adjusted Diluted EPS Fair Market Alliance Boots Acquisition DEA Organizational Alliance Diluted EPS Acquisition Share Issuance Hurricane Related LIFO Value of Gain on Settlement Medicare Efficiency Boots Adjusted Diluted (GAAP) Related Costs Effect Sandy Amortization Provision warr
Slide 34: Reconciliation of Free Cash Flow
Reconciliation of Free Cash Flow $ in Millions 1Q09 2Q09 3Q09 4Q09 1Q10 2Q10 3Q10 4Q10 Cash Flow from Operations (GAAP) $312 $1,428 $1,519 $852 $1,168 $595 $1,056 $925 Capital Expenditures (638) (454) (442) (393) (304) (220) (262) (228) (GAAP) Free Cash Flow (Non-GAAP)* ($326) $974 $1,077 $459 $864
Slide 35: Reconciliation of Free Cash Flow
Reconciliation of Free Cash Flow $ in Millions 1Q11 2Q11 3Q11 4Q11 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 Cash Flow from Operations $1,165 $886 $1,230 $362 $809 $1,007 $1,847 $768 $601 $1,198 $1,379 $1,123 (GAAP) Capital Expenditures (273) (196) (230) (514) (419) (304) (379) (448) (336) (245) (293)
Slide 36: Reconciliation of Free Cash Flow
Reconciliation of Free Cash Flow $ in Millions 1Q14 2Q14 3Q14 Cash Flow from Operations $133 1,104 1,272 (GAAP) Capital Expenditures (364) (227) (230) (GAAP) Free Cash Flow (Non- (231) 877 1,042 GAAP)* *Free cash flow is defined as net cash provided by operating activities in a period minus addition
Slide 37: Reconciliation of FIFO Inventory
Reconciliation of FIFO Inventory $ in Millions except as indicated 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 Total LIFO Inventory $8,231 $7,347 $7,004 $7,036 $7,821 $7,253 $6,881 $6,852 $7,729 $7,213 $6,439 YOY % Change 4.1% (3.4%) (7.3%) (12.5%) (5.0%) (1.3%) (1.8%) (2.6%) (1.2%) (0.6%
Slide 38: Certain Definitions & Assumptions
Certain Definitions & Assumptions CERTAIN ASSUMPTIONS: Unless the context otherwise indicates or requires: • All figures assume constant currency and current management assumptions regarding future interest rates. • References to the combined company and pro forma combined financial and other inform
Slide 39: Cautionary Note Regarding Forward-Looking Statements
Cautionary Note Regarding Forward-Looking Statements Cautionary Note Regarding Forward-Looking Statements. Statements in these materials and the accompanying presentation and remarks that are not historical are forward-looking statements for purposes of applicable securities laws. Words such as “exp
Slide 40: Cautionary Note Regarding Forward-Looking Statements
Cautionary Note Regarding Forward-Looking Statements Important Information for Investors and Shareholders This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale of securities